Researchers identify GFAP as a potent biomarker for predicting dementia risk over a decade before clinical diagnosis, underscoring its potential for early screening and intervention
Share this article The FDA released draft guidance on the use of AI and ML in drug development in May 2023. Image credit: Shutterstock /
WASHINGTON — Lawmakers are considering increasing doctors’ Medicare pay in an upcoming government funding package, but their policy would only partially offset cuts providers saw
Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report. But investors
Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said
Emergency medical service (EMS) systems are not consistently providing optimal care based on new national standards of quality to patients who call 911, according to
Dive Brief: Medicare will start covering Senseonics’ implantable continuous glucose monitor (CGM) for a broader group of patients in late February. Three Medicare Administrative Contractors
Dive Brief: Robotic systems have no effect on the two-year revision rate in cementless total knee replacement patients, an analysis of registry data found. The
The medical technology industry has already shed hundreds of jobs in the first weeks of the year, continuing a top industry trend from 2023. Medtronic,
This January we were treated to a mix of novel psychedelic trials and an unusually large amount of re-analyses of earlier studies. Ibogaine was researched